Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Astrazeneca Plc ADR (NQ: AZN )

54.15 -0.08 (-0.15%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,176
Open 54.15
Bid (Size) 54.76 (11)
Ask (Size) 54.79 (6)
Prev. Close 54.23
Today's Range 54.15 - 54.15
52wk Range 46.48 - 64.21
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AstraZeneca Reinforces Leadership in Breast Cancer at SABCS 2021 With New Data Underscoring Ambition to Redefine Cancer Care
AstraZeneca will underscore its ambition to redefine care with new data from across its portfolio of innovative medicines at the 2021 San Antonio Breast Cancer Symposium (SABCS) December 7-10, 2021. 
From Business Wire News Releases
Valneva's COVID-19 Shot Fails As Booster In Pfizer/BioNTech Vaccinated Population
Valneva SE(NASDAQ: VALN) hasresponded to data publishedfrom the U.K COV-Boost COVID-19 vaccine trial that investigated ... 
Tags VALN why it's moving Biotech
From Benzinga

Performance

YTD
+7.18%
+7.18%
1 Month
-14.17%
-14.17%
3 Month
-7.27%
-7.27%
6 Month
-3.99%
-3.99%
1 Year
-0.21%
-0.21%

More News

Read More
Here's Why AstraZeneca Stock Could Help Make You Rich
Tags Market News AZN Recent Press Releases
From Motley Fool
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?
Tags AZN Recent Press Releases Market News
From Motley Fool
A new study finds that most COVID-19 vaccines boost immunity, though there is no winning shot
Tags NVAX VALN AZN
From MarketWatch
The Implications Behind Genetron Health's Latest Earnings Report
Tags Partner Content GTH Opinion
From Benzinga
DESTINY-Breast11 Neoadjuvant Phase 3 Trial of ENHERTU® Initiated in Patients with High-Risk HER2 Positive Early-Stage Breast Cancer
From Business Wire News Releases
WHO has not seen any reports of deaths caused by omicron variant, urges people not to panic as delta still dominant
Tags UK:AZN BNTX AZN
From MarketWatch
AstraZeneca Blocks SOBI's $8B Buyout, Advent Withdraws The Bid - Report
Tags AZNCF News Market News
From Benzinga
Possible New Links Identified With AstraZeneca COVID-19 Shot, Blood Clots
Tags Benzinga Health Care Biotech
From Benzinga
Is High Pressure Good for Drug Development?
Tags Partner Content Pressure Bio SNY
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.